Safety and feasibility of a tolerogenic dendritic cell-based treatment of multiple sclerosis (MS): a collaborative initiative comparing intranodal and intradermal cell administration in two phase I clinical trials


Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)679-684
Number of pages6
JournalMultiple Sclerosis Journal
Issue number5
Publication statusPublished - 1 Apr 2018
Externally publishedYes
Event34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) - Berlin, Germany
Duration: 10 Oct 201812 Oct 2018

Cite this